オプションチェーンは、Reviva Pharmaceuticalsの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Reviva Pharmaceuticalsの市場センチメントを評価します。.

Reviva Pharmaceuticals (NASDAQ:RVPH) 株価情報, オプションチェーン

REVIVA PHARMACEUTICALS HOLDI

Reviva Pharmaceuticals

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Reviva Pharmaceuticals Holdings, Inc. - Common Stock

Reviva Pharmaceuticals Holdings Inc

Reviva Pharmaceuticals Holdings, Inc. - Warrants

Jefferies analyst Corey Tarlowe maintains Abercrombie &amp; Fitch (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>) with a Buy and lowers the price target from $170 to $135.

News

Price Target

Analyst Ratings

Jefferies Maintains Buy on Abercrombie & Fitch, Lowers Price Target to $135

Trading Ideas

URGN

UroGen Pharma Shares Resume Trade

Jefferies analyst Corey Tarlowe maintains Urban Outfitters (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) with a Underperform and raises the price target from $42 to $46.

URBN

Jefferies Maintains Underperform on Urban Outfitters, Raises Price Target to $46

Goldman Sachs analyst Tito Labarta maintains XP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XP#NASDAQ">XP</a>) with a Neutral and raises the price target from $15 to $17.

Goldman Sachs Maintains Neutral on XP, Raises Price Target to $17

Jefferies analyst Corey Tarlowe maintains Gap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) with a Hold and raises the price target from $26 to $29.

Jefferies Maintains Hold on Gap, Raises Price Target to $29

WIIM

Weibo shares are trading higher following better-than-expected Q1 financial results.

GEO Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) has outperformed the market over the past 5 years by 2.96% on an annualized basis producing an average annual return of 17.6%. Currently, GEO Group has a market capitalization of $3.82 billion. 
Buying $100 In GEO: If an investor had bought $100 of GEO stock 5 years ago, it would be worth $224.96 today based on a price of $27.06 for GEO at the time of writing.
<h3>GEO Group's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747846300_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In GEO Group 5 Years Ago Would Be Worth This Much Today

Workday Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>) is gearing up to report its fiscal first-quarter results on Thursday, May 22.
The company is likely to report a revenue and earnings beat, while "some late quarter deal slippage" may result in lower cRPO (current remaining performance obligation) upside than posted in the previous quarter, according to Needham.
The Workday Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587635595064ed000140010c/scott-berg">Analyst Scott Berg</a> reaffirmed a Buy rating and price target of $300.
The Workday Thesis: Industry checks suggest the company witnessed "relatively stable demand" in the first quarter, although its sales cycles expanded for some larger deals and were pushed into the second quarter, Berg said in the note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Workday may beat expectations, "with core HCM among enterprise businesses showing relative strength," he added.
The company is likely to reiterate its full-year cRPO guidance, although its overall pipeline activity "appears favorable," the analyst stated.
"We think current operating margin guidance is conservative given the company&#8217;s February RIF even as we expect incremental investment in AI functionality," he further wrote.
WDAY Price Action: Shares of Workday had declined by 0.11% to $273.55 at the time of publication on Wednesday.
Read More: <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45262278/under-armour-faces-tough-road-ahead-says-analyst"> </a> • <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45262278/under-armour-faces-tough-road-ahead-says-analyst">Workday Could Soar With AI Strategy, Says Analyst</a>
Photo: Shutterstock

Analyst Color

Previews

Reiteration

WDAY

Workday Analysts Expects Q1 Revenue, Earnings Upside

Goldman Sachs analyst Vitor Tomita maintains Grupo Televisa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TV#NYSE">TV</a>) with a Buy and raises the price target from $1.8 to $2.2.

Goldman Sachs Maintains Buy on Grupo Televisa, Raises Price Target to $2.2

Trading Halt: Halt status updated at 12:50:00 PM ET: Quotation Resumption: News and Resumption Times

MARA Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) shares climbed 6.1% to $17.18 Wednesday afternoon, buoyed by Bitcoin&#8217;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) surge to a new <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45547618/bitcoin-hits-all-time-high-of-109500-whats-next">all-time high</a> of $109,500. As a leading Bitcoin mining company, Marathon&#8217;s profitability and asset value are directly tied to the cryptocurrency&#8217;s performance.
What To Know: Marathon benefits in two key ways from Bitcoin&#8217;s rally. First, the higher Bitcoin price increases the dollar value of the Bitcoin it mines, boosting mining revenue.
Second, Marathon strategically holds a significant amount of Bitcoin on its balance sheet, meaning the appreciation of Bitcoin directly increases the value of its existing treasury holdings. This &#8220;leveraged play&#8221; on Bitcoin makes MARA an attractive option for investors seeking exposure to the digital asset&#8217;s upside.
Bitcoin&#8217;s robust recovery, driven by technical momentum, a favorable macroeconomic environment and <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45547618/bitcoin-hits-all-time-high-of-109500-whats-next">significant short liquidations</a>, has fostered strong bullish sentiment. This positive backdrop, reinforced by growing institutional adoption and fundamental strength directly underpins Marathon Digital&#8217;s stock performance.
Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45547100/xrp-up-2-5-as-ripple-ceo-brad-garlinghouse-invites-pro-bitcoin-senator-lummis-to-public-discussion">XRP Up 2.5% As Ripple CEO Brad Garlinghouse Invites Pro-Bitcoin Senator Lummis To Public Discussion</a>
<h2 class="wp-block-heading">How To Buy MARA Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in MARA Holdings&#8217; case, it is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, MARA has a 52-week high of $30.28 and a 52-week low of $9.81.

$BTC

MARA

Bitcoin's New All-Time High Fuels Marathon Holdings (MARA) Stock: What's Going On?

Ohmyhome shares are trading lower after the company announced a registered direct offering of 4.04 million ordinary shares at $0.45 per share.

Goldman Sachs analyst Kash Rangan maintains Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) with a Buy and raises the price target from $480 to $550.

MSFT

Goldman Sachs Maintains Buy on Microsoft, Raises Price Target to $550

CMTG

Claros Mortgage Trust shares are trading higher. UBS raised its price target on the stock from $3.5 to $4 and maintained a Buy rating.

Goldman Sachs analyst Brett Feldman maintains IHS Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHS#NYSE">IHS</a>) with a Neutral and raises the price target from $4 to $5.

Goldman Sachs Maintains Neutral on IHS Holding, Raises Price Target to $5

Canada Goose Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOOS#NYSE">GOOS</a>) shares are surging Wednesday after the company reported better-than-expected results for the fourth quarter. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/25/05/b45538062/canada-goose-reports-fourth-quarter-and-full-year-fiscal-2025-results">of the report</a>.
Q4 Earnings: Canada Goose reported fiscal fourth-quarter revenue of 384.6 million Canadian dollars ($267.92 million), beating analyst estimates, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The company reported fourth-quarter adjusted earnings of CA$0.33 per share, which also beat analyst estimates.
Total revenue was up 7.4% year-over-year, and inventory declined 14% year-over-year. Direct-to-consumer revenue was up 15.7% to CA$314.1 million, while Wholesale revenue fell 23.2% to CA$31.8 million. 
&#8220;Our strong&nbsp;Q4&nbsp;results show the kind of impact Canada Goose can make when our brand connects and our strategy hits the mark,&#8221; said Dani Reiss, chairman and CEO of Canada Goose. 
&#8220;We saw solid DTC comparable sales growth, fueled by compelling storytelling, sharp retail execution, and the continued momentum around our Snow Goose capsule. As we close out fiscal 2025, we are making clear strides across our key priorities – enhancing retail execution, elevating our brand and product offering, and delivering it all, efficiently.&#8221;
Canada Goose did not provide forward guidance, citing ongoing macroeconomic uncertainty and dynamic consumer spending patterns brought on by an unpredictable global trade environment.
GOOS Price Action: <a href="http://benzinga.com/quote/goos" target="_blank" rel="noreferrer noopener">Canada Goose shares</a> were up 28.4% at $11.45 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45540766/tjx-boosts-q1-sales-with-more-shoppers-says-tariffs-wont-hurt-2026-outlook">TJX Boosts Q1 Sales With More Shoppers, Says Tariffs Won&#8217;t Hurt 2026 Outlook</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/kaskip">kaskip</a>/Shutterstock.

Earnings

Movers

GOOS

Canada Goose Stock Soars On 'Strong' Q4 Earnings, Company Holds Back Guidance Due To 'Macroeconomic Uncertainty'

Bank of America Securities analyst Vivek Arya maintained a Buy rating on Advanced Micro Devices, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) with a <a href="https://www.benzinga.com/quote/AMD/analyst-ratings" target="_blank" rel="noreferrer noopener">price target of $130</a> on Tuesday.
The company benefits from continued Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) CPU share gains in server and PC, a rising tide in AI with higher content from upcoming rack-scale pipeline, along with related Middle East $10 billion multi-year contracts, and cyclical recovery, the analyst noted.
Arya&#8217;s segment analysis shows:
<ul class="wp-block-list">
<li>EPS power of $6.44 and $8.52 in the calendar year 2026 and 2027, or 15% and 20% above the Street consensus</li>
<li>A breadth of ownership across large-cap US active fund managers falling to only ~23% (versus May 2024 peak of 40%+ ownership)</li>
<li>Relative weightage versus SPX of only 0.2 times (versus a peak of 0.8 times year-on-year), as per the analyst&#8217;s BofA strategy data.</li>
</ul>
Valuation at just 20 times and 16 times PE on current calendar year 2026 and 2027 consensus (or 18 times and 13 times PE on Arya&#8217;s EPS power scenario) seems too compelling for a high-quality compute franchise with consistent management execution capable of growing topline 20%+ and adjusted EPS 30%+ for the next few years as per Arya.
Also Read: <a href="https://www.benzinga.com/tech/25/05/45542185/amd-unveils-powerful-new-ai-gaming-chips-at-computex-to-challenge-nvidia" target="_blank" rel="noreferrer noopener">AMD Unveils Powerful New AI, Gaming Chips At Computex To Challenge Nvidia</a>
The analyst also flagged AMD&#8217;s recent $6 billion addition to its buyback program.
Even though Arya expects Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) (80%+ share) and custom chips (10-15% share) to dominate, he noted AMD could be a credible 3%-4% share of the over $300 billion-$400 billion TAM in AI accelerator.
He said many customers have significant internal workloads and compute requirements for internal teams, and AMD can play an essential role.
Arya noted that the company&#8217;s recent acquisitions of rack-scale systems and improved software position it well, and it has received several public recognitions at Oracle Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), xAI, and others.
He expects AMD to showcase an impressive set of partners and AI pipeline across accelerators, systems, software, CPU, and networking at its upcoming June 12 AI event.
Overall, Arya noted potential upside in each of the following end markets Data Center CPU, Data Center GPU, Client/PC CPU, Gaming Consoles, and Embedded for an aggregate sales upside of ~$6.6 billion by calendar year 2027.
Price Action:&nbsp;AMD stock traded higher by 1.76% to $115.46 at Wednesday&#8217;s last check.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/asset-sales/25/05/45522354/intel-eyes-exit-from-networking-and-edge-business-to-refocus-on-pc-data-center-dominance-report" target="_blank" rel="noreferrer noopener">Intel Eyes Exit From Networking And Edge Business To Refocus On PC, Data Center Dominance: Report</a></li>
</ul>
Image: Shutterstock

Tech

INTC

NVDA

ORCL

AMD Could See EPS Upside By 2027 Despite Nvidia's Over 80% Market Share: Analyst

Goldman Sachs analyst Brooke Roach maintains Amer Sports (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AS#NYSE">AS</a>) with a Buy and raises the price target from $28 to $44.

Goldman Sachs Maintains Buy on Amer Sports, Raises Price Target to $44

JPMorgan analyst Christopher Horvers reiterated the Neutral rating <a href="https://www.benzinga.com/quote/TGT/analyst-ratings" target="_blank" rel="noreferrer noopener">on </a><a href="https://www.benzinga.com/quote/TGT/analyst-ratings" target="_blank" rel="noreferrer noopener">Target Corporation</a><a href="https://www.benzinga.com/quote/TGT/analyst-ratings" target="_blank" rel="noreferrer noopener"> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) on Wednesday.</a>
Today, Target registered first-quarter sales of $23.85 billion (down 2.8% year over year), which missed the Street view of $24.32 billion.
The retail giant lowered its FY2025 adjusted EPS guidance from $8.80–$9.80 to $7.00–$9.00.
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/25/05/45535402/target-lowes-and-3-stocks-to-watch-heading-into-wednesday" rel="noreferrer noopener">Target, Lowe's And 3 Stocks To Watch Heading Into Wednesday</a>
Following Target&#8217;s earnings release, analyst Horvers noted that first-quarter comps and EPS aligned with bearish expectations, while the full-year guidance cut met expectations at the lower end of the range.
The analyst pointed out that weak comp performance and a gross margin miss, along with an 11% year-over-year increase in inventory, played into the bear case.
However, the updated full-year outlook appeared more favorable at the higher end, with bears generally expecting EPS between $7 and $8. Meanwhile, CNBC <a target="_blank" href="https://www.cnbc.com/2025/05/21/target-tgt-q1-2025-earnings.html" rel="noreferrer noopener">highlighted </a>in a report that Target cited discretionary spending pressure tied to tariff uncertainty and recent DEI-related announcements.
Horvers emphasized that the elevated inventory levels in discretionary categories remain a key concern, especially considering how markdowns will impact both revenue and margins.
The degree of promotional activity required to clear inventory remains a critical variable, particularly as Target was seen as the most negatively positioned name in his coverage universe going into the print.
He also noted that the stock closed yesterday trading at 14x the low end of guidance, while bears argue for a 12x multiple.
Price Action: TGT shares are trading lower by 3.76% to $94.42 at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/05/45517463/top-2-risk-off-stocks-that-are-ticking-portfolio-bombs" target="_blank" rel="noreferrer noopener">Top 2 Risk Off Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>

Equities

Guidance

Markets

General

Target Under Strain? Analyst Cautions On Inventory, Margins, Tariff Uncertainty

Stifel analyst Jim Duffy maintains Warby Parker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRBY#NYSE">WRBY</a>) with a Hold and raises the price target from $18 to $21.

WRBY

Stifel Maintains Hold on Warby Parker, Raises Price Target to $21

Press Releases

Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit

Reviva to Participate in the 2025 BIO CEO & Investor Conference

Reviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Health Care

Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress

Reviva Reports Full Year 2024 Financial Results and Recent Business Highlights

Reviva to Present Late-Breaking Poster on the RECOVER Long-term Open Label Extension Trial for Brilaroxazine in Schizophrenia at the 2025 ASCP Annual Meeting

Comments

Reviva Pharmaceuticals

Reviva Pharmaceuticals (RVPH) オプション

Reviva Pharmaceuticals (NASDAQ:RVPH) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル